Ligand validation:2VXL

UDP: URIDINE-5'-DIPHOSPHATE

UDP is a Ligand Of Interest in 2VXL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2VXL_UDP_A_401	60%	34%	0.193	0.979	0.95	1.63	-	5	0	0	100%	1
1GX4_UDP_A_401	100%	32%	0.046	0.991	1.68	1.03	2	3	0	0	100%	1
2WGZ_UDP_A_1401	96%	37%	0.075	0.986	0.94	1.5	1	5	0	0	100%	1
1GWW_UDP_B_1369	92%	41%	0.077	0.967	1.26	1.04	3	2	0	0	100%	1
2VS3_UDP_A_401	91%	36%	0.09	0.978	0.95	1.54	-	5	0	0	100%	1
1GX0_UDP_A_1369	90%	22%	0.084	0.968	2.06	1.18	4	4	0	0	100%	1
8X3Q_UDP_C_401	100%	3%	0.015	0.998	3.32	2.69	13	13	0	0	100%	1
8X3U_UDP_B_401	100%	3%	0.012	0.999	3.31	2.68	13	13	2	0	100%	1
8VH8_UDP_C_704	100%	62%	0.032	0.995	0.55	0.9	-	1	0	0	100%	1
2B69_UDP_A_900	100%	42%	0.032	0.992	1.03	1.21	2	4	0	0	100%	1
4GYW_UDP_C_1101	100%	37%	0.037	0.988	1.03	1.45	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.